Abstract:A series of myricetin derivatives containing quinazoline thioether moiety were designed and synthesized using myricetrin as the starting material through active splicing strategy. All target compounds were characterized by H-1 NMR, C-13 NMR, F-19 NMR and HRMS. Their biological activities were evaluated. The results of biological activities showed that these compounds exhibited certain inhibitory activities against X. oryzae, X. citri and R. solanacearum. Among them, 3-(3-((6-bromoquinazolin-4-yl)thio)propoxy)-5,7-dimethoxy-2-(3,4,5-trimethoxyphenyl)-4H-chromen-4-one (A(15)) displayed appreciable inhibitory effect against X. oryzae with a half maximal effective concentration (EC50) values of 13.9 mu g/mL, which was better than those of the control drugs of bismerthiazol (88.9 mu g/mL) and thiodiazole-copper (68.1 mu g/mL). The EC50 values of 3-(4((6-chloroquinazolin- 4-yl)thio)butoxy)-5,7-dimethoxy- 2-(3,4,5-trimethoxyphenyl)-4H-chromen-4-one (A(3)), 3-(3-((6-chloroquinazolin-4-yl)thio)propoxy)-5,7-dimethoxy-2-(3,4,5-trimethoxyphenyl)-4H-chromen-4-one (A(14)), 3-(3-((6-chloroquinazolin4-yl)thio)propoxy)-5,7-dimethoxy-2-(3,4,5-trimethoxyphenyl)-4H-chromen-4-one (A(15)) and 3-(3-((6-fluoroquinazolin-4-yl)thio)propoxy)-5,7-dimethoxy-2-(3,4,5-trimethoxyphenyl)-4H-chromen-4-one (A(16)) against Ralstonia solanacearum were 1.1, 14.0, 11.9 and 7.5 mu g/mL, respectively, which were superior to the control drugs of bismerthiazol (38.5 mu g/mL) and thio-diazole-copper (184.8 mu g/mL). The results of in vivo experiments showed that compound A(15) has good curative and protective activities against X. oryzae. The possible antibacterial mechanisms of target compound A(3) against R. solanacearum and A(15) against X. oryzae were preliminarily discussed base on scanning electron microscope analyses.

Synthesis and Biological of Novel Myricetin Derivatives Containing 1,3,4-Oxadiazoles

Synthesis and Biological Activity of Myricetin Derivatives Containing 1,3,4-Thiadiazole Scaffold

Design, Synthesis, and Biological Activity of Novel Myricetin Derivatives Containing Amide, Thioether, and 1,3,4-Thiadiazole Moieties

Synthesis and Biological Activities of Myricetin Derivatives Containing Quinoxaline

Synthesis and Antibacterial and Antiviral Activities of Myricetin Derivatives Containing a 1,2,4-Triazole Schiff Base

Design, Synthesis and Antibacterial Activities Against Xanthomonas Oryzae Pv. Oryzae, Xanthomonas Axonopodis Pv. Citri and Ralstonia Solanacearum of Novel Myricetin Derivatives Containing Sulfonamide Moiety

Design, Synthesis, and Antibacterial Activity of Novel Myricetin Derivatives Containing Sulfonate

Design, Synthesis, Antibacterial Activity, Antiviral Activity, and Mechanism of Myricetin Derivatives Containing a Quinazolinone Moiety

Synthesis and Antibacterial Activities of Myricetin Derivatives Containing Acidamide Moiety

Antimicrobial Evaluation of Myricetin Derivatives Containing Benzimidazole Skeleton Against Plant Pathogens

Synthesis and Antibacterial Activity of Novel Myricetin Derivatives Containing Sulfonylpiperazine

Design, Synthesis, Biological Activity Evaluation and Action Mechanism of Myricetin Derivatives Containing Thiazolebisamide

Synthesis And Antiviral Activity Of Novel Myricetin Derivatives Containing Ferulic Acid Amide Scaffolds

Antiviral Activities of Novel Myricetin Derivatives Containing 1,3,4‐Oxadiazole Bisthioether

Synthesis of Novel 1,3,4-Oxadiazole Derivatives Containing Diamides As Promising Antibacterial and Antiviral Agents

Design, synthesis, and antiviral activities of myricetin derivatives containing pyridazinone

Design, Synthesis and Biological Activities of Myricetin Derivatives Containing Quinazoline Thioether Moiety

Antibacterial and Antiviral Activities and Action Mechanism of Flavonoid Derivatives with a Benzimidazole Moiety

Design, synthesis, and antiviral activities of Myricetin derivatives containing Phenoxypyridine

Design, Synthesis, and Biological Activity Studies of Myricetin Derivatives Containing a Diisopropanolamine Structure

Design, Synthesis, Biological Activity Evaluation and Mechanism of Action of Myricetin Derivatives Containing Thioether Quinazolinone